Pressure Biosciences Inc
Pressure BioSciences, Inc. develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide. The company's products/services are based on Ultra Shear Technology platform, which turns hydrophobic oil-based supplements, therapeutics, and other active ingredients to water-soluble, bioavailable, oil-in-water nano emulsion formul… Read more
Market Cap & Net Worth: Pressure Biosciences Inc (PBIO)
Pressure Biosciences Inc (OTCQB:PBIO) has a market capitalization of $184.35K ($184.35K) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #43801 globally and #13967 in its home market, demonstrating a -66.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pressure Biosciences Inc's stock price $0.00 by its total outstanding shares 40967084 (40.97 Million).
Pressure Biosciences Inc Market Cap History: 2015 to 2025
Pressure Biosciences Inc's market capitalization history from 2015 to 2025. Data shows change from $417.86 Million to $184.35K (-54.03% CAGR).
Pressure Biosciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pressure Biosciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.84x
Pressure Biosciences Inc's market cap is 6.84 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $417.86 Million | $1.80 Million | -$7.42 Million | 232.44x | N/A |
| 2016 | $245.80 Million | $1.98 Million | -$2.71 Million | 124.36x | N/A |
| 2017 | $143.38 Million | $2.24 Million | -$10.72 Million | 64.00x | N/A |
| 2018 | $92.18 Million | $2.46 Million | -$9.70 Million | 37.50x | N/A |
| 2019 | $51.21 Million | $1.81 Million | -$11.66 Million | 28.29x | N/A |
| 2020 | $86.85 Million | $1.22 Million | -$16.01 Million | 71.15x | N/A |
| 2021 | $94.63 Million | $2.00 Million | -$20.15 Million | 47.26x | N/A |
| 2022 | $53.26 Million | $1.73 Million | -$16.08 Million | 30.80x | N/A |
| 2023 | $13.52 Million | $1.98 Million | -$29.31 Million | 6.84x | N/A |
Competitor Companies of PBIO by Market Capitalization
Companies near Pressure Biosciences Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Pressure Biosciences Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Pressure Biosciences Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Pressure Biosciences Inc's market cap moved from $417.86 Million to $ 184.35K, with a yearly change of -54.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $184.35K | +50.00% |
| 2024 | $122.90K | -99.09% |
| 2023 | $13.52 Million | -74.62% |
| 2022 | $53.26 Million | -43.72% |
| 2021 | $94.63 Million | +8.96% |
| 2020 | $86.85 Million | +69.60% |
| 2019 | $51.21 Million | -44.44% |
| 2018 | $92.18 Million | -35.71% |
| 2017 | $143.38 Million | -41.67% |
| 2016 | $245.80 Million | -41.18% |
| 2015 | $417.86 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Pressure Biosciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $184.35K USD |
| MoneyControl | $184.35K USD |
| MarketWatch | $184.35K USD |
| marketcap.company | $184.35K USD |
| Reuters | $184.35K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.